1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 25 JANUARY 2016

Cancer Drug News 25 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Leveraging Novel Diagnostic Approaches For More Favourable Outcomes
Industry Brief - Biocad's Trastuzumab Approved In Russia
Industry Brief - Kyowa Hakko Kirin Enters Rituximab Agreement With Sandoz
Industry Brief - European Commission Approves Label Variation For Adcetris
Industry Trend Analysis - First-Line Approval Needed To Improve Kyprolis' Competitive Edge
Industry Brief - AbbVie's Venetoclax Receives FDA Breakthrough Therapy Designation For r/r CLL
Industry Brief - Oncaspar Gains EU Approval For ALL In Combination Therapy
Industry Brief - FDA Approves Arzerra As Maintenance Therapy For Relapsed CLL
Industry Brief - OncoGenex' Apatorsen Phase II Combination Study In NSCLC Fails To Show PFS Benefit
Industry Trend Analysis - Pricing Issues Will Force Pharma Firms To Tread Warily Ahead Of US Elections
Industry Brief - Opdivo+Yervoy Regimen Receives FDA Approval In BRAF V600 Mutant MM
Industry Brief - Philogen Begins Pivotal Melanoma Trial; Reports Pfizer ADC Deal Update
Industry Brief - FDA Grants ODD To Immunocore's IMCgp100 For Uveal Melanoma
Industry Brief - NICE Recommends Opdivo
Industry Brief - Immunocore Begins Phase Ib/II Combination Trial Of IMCgp100 In Melanoma
Industry Brief - Dako Receives Expanded FDA Approval For PD-L1 Test To Include Melanoma
Industry Trend Analysis - Rising Awareness And Early Detection Will Support Tackling Of Women's Cancer
Industry Brief - Biocad To Supply Anticancer Biosimilars Outside Russia
Industry Brief - Cancer Conferences - April 2016

Table Of Contents

Cancer Drug News 25 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.